| 武汉天德生物病理生物芯片系列-BRC1023 | |||||||||
| 芯片编号 | BRC1023 | ||||||||
| 芯片名称 | 乳腺癌,102例,102芯(1.5mm) BRC1023 | ||||||||
| 芯片说明 | 三阴性乳腺癌组织芯片,102例,102芯,包括正常/良性(5例)和癌(97例)组织,提供分级及TNM分期数据。 | ||||||||
| 点数: | 102芯 | ||||||||
| 例数: | 102例 | ||||||||
| 组织固定方式: | 福尔马林固定24h | ||||||||
| QA/QC: | HE染色和IHC染色 | ||||||||
| 应用: | 常规组织学操作包括免疫组织化学(IHC)和原位杂交(ISH),可以在我们的技术支持页面找到操作流程。 | ||||||||
| 注意事项: | 1.收到产品后请常温保存,并在24个月内使用,2.请在实验前60°烤片30分钟,3.请选择温和的修复方式,以免造成组织脱落。 | ||||||||
| 位置 | 年龄 | 性别 | 标本部位 | 病理分类 | 病理分级 | TNM_T | TNM_N | TNM_M | 备注 |
| A1 | 45 | F | 乳腺,Breast | 正常;Normal | |||||
| A2 | 43 | F | 乳腺,Breast | 正常;Normal | |||||
| A3 | 48 | F | 乳腺,Breast | 正常;Normal | |||||
| A4 | 49 | F | 乳腺,Breast | 正常;Normal | |||||
| A5 | 36 | F | 乳腺,Breast | 正常;Normal | |||||
| A6 | 50 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II~III | T2 | N0 | M0 | ER(-)、PR(-)、Her-2(0) |
| A7 | 59 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II | T2 | N0 | M0 | ER(-)、PR(-)、Her-2(0) |
| A8 | 49 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II~III | T2 | N0 | M0 | ER(-)、PR(-)、Her-2(0) |
| A9 | 46 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | III | T2 | N0 | M0 | ER(-)、PR(-)、Her-2(0) |
| A10 | 32 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | III | T3 | N0 | M0 | ER(-)、PR(-)、Her-2(0) |
| A11 | 56 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | I | Tis | N1 | M0 | ER(-)、PR(-)、Her-2(0) |
| A12 | 29 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | III | T3 | N0 | M0 | ER(-)、PR(-)、Her-2(0) |
| A13 | 38 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II | T2 | N3 | M0 | ER(-)、PR(-)、Her-2(0) |
| B1 | 54 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II | T2 | N0 | M0 | ER(-)、PR(-)、Her-2(0) |
| B2 | 70 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II | T2 | N0 | M0 | ER(-)、PR(-)、Her-2(0) |
| B3 | 69 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II | T2 | N1 | M0 | ER(-)、PR(-)、Her-2(0) |
| B4 | 26 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II | T1 | N1 | M0 | ER(-)、PR(-)、Her-2(0) |
| B5 | 57 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | III | T2 | N0 | M0 | ER(-)、PR(-)、Her-2(0) |
| B6 | 51 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | III | T2 | N0 | M0 | ER(-)、PR(-)、Her-2(0) |
| B7 | 43 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II | T2 | N0 | M0 | ER(-)、PR(-)、Her-2(0) |
| B8 | 65 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | III | T2 | N0 | M0 | ER(-)、PR(-)、Her-2(0) |
| B9 | 41 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II | T2 | N2 | M0 | ER(-)、PR(-)、Her-2(0) |
| B10 | 41 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II | T2 | N2 | M0 | ER(-)、PR(-)、Her-2(0) |
| B11 | 47 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II | T3 | N1 | M0 | ER(-)、PR(-)、Her-2(0) |
| B12 | 62 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | III | T3 | N0 | M0 | ER(-)、PR(-)、Her-2(0) |
| B13 | 57 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II | T2 | N0 | M0 | ER(-)、PR(-)、Her-2(0) |
| C1 | 45 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | III | T2 | N0 | M0 | ER(-)、PR(-)、Her-2(0) |
| C2 | 27 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II | T1 | N0 | M0 | ER(-)、PR(-)、Her-2(0) |
| C3 | 53 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | III | T2 | N0 | M0 | ER(-)、PR(-)、Her-2(0) |
| C4 | 53 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | III | T2 | N0 | M0 | ER(-)、PR(-)、Her-2(0) |
| C5 | 46 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | III | T2 | N0 | M0 | ER(-)、PR(-)、Her-2(0) |
| C6 | 67 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II | T2 | N0 | M0 | ER(-)、PR(-)、Her-2(0) |
| C7 | 50 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II | T2 | N0 | M0 | ER(-)、PR(-)、Her-2(0) |
| C8 | 37 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II | T2 | N0 | M0 | ER(-)、PR(-)、Her-2(0) |
| C9 | 32 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | III | T3 | N0 | M0 | ER(-)、PR(-)、Her-2(0) |
| C10 | 41 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II | T2 | N0 | M0 | ER(-)、PR(-)、Her-2(0) |
| C11 | 36 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II | T2 | N0 | M0 | ER(-)、PR(-)、Her-2(0) |
| C12 | 61 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II | T2 | N1 | M0 | ER(-)、PR(-)、Her-2(0) |
| C13 | 36 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II | T2 | N0 | M0 | ER(-)、PR(-)、Her-2(0) |
| D1 | 76 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II | T2 | N0 | M0 | ER(-)、PR(-)、Her-2(0) |
| D2 | 51 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | III | T2 | N0 | M0 | ER(-)、PR(-)、Her-2(0) |
| D3 | 44 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | III | T2 | N0 | M0 | ER(-)、PR(-)、Her-2(0) |
| D4 | 40 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | III | T2 | N3 | M0 | ER(-)、PR(-)、Her-2(0) |
| D5 | 56 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II | T2 | N3 | M0 | ER(-)、PR(-)、Her-2(0) |
| D6 | 39 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II | T2 | N0 | M0 | ER(-)、PR(-)、Her-2(0) |
| D7 | 54 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | III | T2 | N1 | M0 | ER(-)、PR(-)、Her-2(0) |
| D8 | 57 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | III | T2 | N1 | M0 | ER(-)、PR(-)、Her-2(0) |
| D9 | 60 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | III | T3 | N2 | M0 | ER(-)、PR(-)、Her-2(0) |
| D10 | 49 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II | T3 | N1 | M0 | ER(-)、PR(-)、Her-2(0) |
| D11 | 55 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II | T2 | N0 | M0 | ER(-)、PR(-)、Her-2(0) |
| D12 | 44 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II | T2 | N0 | M0 | ER(-)、PR(-)、Her-2(0) |
| D13 | 46 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II | T2 | N0 | M0 | ER(-)、PR(-)、Her-2(0) |
| E1 | 56 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II | T2 | N0 | M0 | ER(-)、PR(-)、Her-2(0) |
| E2 | 55 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II | T2 | N0 | M0 | ER(-)、PR(-)、Her-2(0) |
| E3 | 45 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II | T2 | N0 | M0 | ER(-)、PR(-)、Her-2(0) |
| E4 | 47 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II | T2 | N0 | M0 | ER(-)、PR(-)、Her-2(0) |
| E5 | 80 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II | T2 | N0 | M0 | ER(-)、PR(-)、Her-2(0) |
| E6 | 66 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | III | T4 | N3 | M0 | ER(-)、PR(-)、Her-2(0) |
| E7 | 30 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | III | T3 | N2 | M0 | ER(-)、PR(-)、Her-2(0) |
| E8 | 44 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II | T3 | N1 | M0 | ER(-)、PR(-)、Her-2(0) |
| E9 | 49 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II | T2 | N0 | M0 | ER(-)、PR(-)、Her-2(0) |
| E10 | 37 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II | T2 | N0 | M0 | ER(-)、PR(-)、Her-2(0) |
| E11 | 55 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | III | T2 | N1 | M0 | ER(-)、PR(-)、Her-2(0) |
| E12 | 50 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II | T2 | N1 | M0 | ER(-)、PR(-)、Her-2(0) |
| E13 | 42 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II | T2 | N1 | M0 | ER(-)、PR(-)、Her-2(0) |
| F1 | 60 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II | T2 | N0 | M0 | ER(-)、PR(-)、Her-2(0) |
| F2 | 65 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | III | T2 | N0 | M0 | ER(-)、PR(-)、Her-2(0) |
| F3 | 50 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | III | T2 | N0 | M0 | ER(-)、PR(-)、Her-2(0) |
| F4 | 46 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | III | T2 | N0 | M0 | ER(-)、PR(-)、Her-2(0) |
| F5 | 39 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II | T2 | N3 | M0 | ER(-)、PR(-)、Her-2(0) |
| F6 | 47 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II | T2 | N0 | M0 | ER(-)、PR(-)、Her-2(0) |
| F7 | 53 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | III | T2 | N2 | M0 | ER(-)、PR(-)、Her-2(0) |
| F8 | 44 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | III | T3 | N0 | M0 | ER(-)、PR(-)、Her-2(0) |
| F9 | 57 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II | T2 | N1 | M0 | ER(-)、PR(-)、Her-2(0) |
| F10 | 75 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | I~II | T3 | N0 | M0 | ER(-)、PR(-)、Her-2(0) |
| F11 | 52 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II | T2 | N1 | M0 | ER(-)、PR(-)、Her-2(0) |
| F12 | 52 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II | T2 | N1 | M1 | ER(-)、PR(-)、Her-2(0) |
| F13 | 47 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II | T2 | N0 | M0 | ER(-)、PR(-)、Her-2(0) |
| G1 | 59 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | III | T4 | N1 | M1 | ER(-)、PR(-)、Her-2(0) |
| G2 | 48 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II | T2 | N1 | M0 | ER(-)、PR(-)、Her-2(0) |
| G3 | 48 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II | T2 | N1 | M0 | ER(-)、PR(-)、Her-2(0) |
| G4 | 50 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | III | T2 | N0 | M0 | ER(-)、PR(-)、Her-2(0) |
| G5 | 71 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | III | T2 | N1 | M0 | ER(-)、PR(-)、Her-2(0) |
| G6 | 60 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | III | T4 | N0 | M0 | ER(-)、PR(-)、Her-2(0) |
| G7 | 60 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | III | T2 | N0 | M0 | ER(-)、PR(-)、Her-2(0) |
| G8 | 37 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | III | T2 | N1 | M0 | ER(-)、PR(-)、Her-2(0) |
| G9 | 54 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | III | T2 | N0 | M0 | ER(-)、PR(-)、Her-2(0) |
| G10 | 45 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | III | T2 | N2 | M0 | ER(-)、PR(-)、Her-2(0) |
| G11 | 45 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | III | T2 | N2 | M0 | ER(-)、PR(-)、Her-2(0) |
| G12 | 66 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | III | T3 | N0 | M0 | ER(-)、PR(-)、Her-2(0) |
| H1 | 46 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | III | T2 | N3 | M0 | ER(-)、PR(-)、Her-2(0) |
| H2 | 49 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | III | T2 | N3 | M0 | ER(-)、PR(-)、Her-2(0) |
| H3 | 50 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | III | T3 | N0 | M0 | ER(-)、PR(-)、Her-2(0) |
| H4 | 62 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | III | T2 | N0 | M0 | ER(-)、PR(-)、Her-2(0) |
| H5 | 50 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | III | T2 | N0 | M0 | ER(-)、PR(-)、Her-2(0) |
| H6 | 43 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | III | T2 | N0 | M0 | ER(-)、PR(-)、Her-2(0) |
| H7 | 67 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | III | T4 | N1 | M0 | ER(-)、PR(-)、Her-2(0) |
| H8 | 52 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | III | T2 | N1 | M0 | ER(-)、PR(-)、Her-2(0) |
| H9 | 45 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | III | T2 | N3 | M0 | ER(-)、PR(-)、Her-2(0) |
| H10 | 49 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | III | T4 | N2 | M0 | ER(-)、PR(-)、Her-2(0) |
| H11 | 61 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | III | T2 | N1 | M0 | ER(-)、PR(-)、Her-2(0) |
| H12 | 79 | F | 乳腺,Breast | 浸润性导管癌;Invasive ductal carcinoma | II | T4 | N1 | M0 | ER(-)、PR(-)、Her-2(0) |